Time is tissue

Vascular surgery is a high-stakes environment where every minute matters.

Patient complexity and comorbidities make diagnosis challenging, often stretching the limits of conventional measurement methods. By integrating microcirculation assessment into the clinical workflow, you can:

• Gain objective insight into tissue perfusion.
• Reduce uncertainty about blood flow.
• Increase confidence in tissue viability assessment.

Constant urgency

Each year, around 150,000 non-traumatic leg amputations take place in the United States, most of which affect people with diabetes [1]. That’s a limb lost every 3.5 minutes.

Behind every case lies complexity. Diabetes, kidney disease, and peripheral artery disease blur the clinical picture, making a timely diagnosis challenging.

The constant urgency surrounding vascular patients and the broad range of conditions they present — from critical and acute limb-threatening ischemia to vascular trauma — stretches traditional diagnostic methods to the limit.  And when tools like ABI and TBI fall short, showing only part of the patient’s condition, decisions are made with incomplete data.

Fewer interventions, lower failure rates

As patients are referred, our solutions provide both macrovascular insights to support diagnosis of vascular diseases such as PAD and CTLI and microcirculation insights for tissue viability and wound healing potential. For patients with amputated toes or non-compressible arteries, skin perfusion pressure (SPP) or transcutaneous oxygen (TcpO2) offer reliable alternatives to ABI and TBI.

These deep, objective insights support confident clinical decisions, whether to discharge, pursue conservative treatment, or determine the appropriate surgical approach — helping to reduce the number of interventions and lower failure rates through data-driven care.

Perioperative insights

PeriFlux 6000 and PeriCam PSI provide a layered view of tissue perfusion:

• Macrovascular — ABI, TBI, and PVR.
• Microvascular — skin perfusion pressure (SPP) and transcutaneous oxygen (TcpO2).
• Perfusion imaging.

Our robust measurement technology delivers consistent, high-quality data at every stage, enabling accurate pre-, intra-, and post-operative assessment of wound healing, treatment planning, and evaluation.

As patients are referred, our solutions provide both macrovascular insights to support diagnosis of vascular diseases such as PAD and CTLI and microcirculation insights for tissue viability and wound healing potential. For patients with amputated toes or non-compressible arteries, skin perfusion pressure (SPP) or transcutaneous oxygen (TcpO2) offer reliable alternatives to ABI and TBI.

These deep, objective insights support confident clinical decisions, whether to discharge, pursue conservative treatment, or determine the appropriate surgical approach — helping to reduce the number of interventions and lower failure rates through data-driven care.

PeriFlux 6000

AI-generated background; product and clinical use unchanged.

Our state-of-the-art vascular solution supports a full range of macro- and microcirculation measurements. Its laser Doppler technology and advanced signal processing ensure that PeriFlux 6000 delivers robust measurements, making it ideal for vascular assessment and follow-up.

PeriCam PSI

PeriCam PSI uses laser speckle contrast imaging (LSCI) to provide real-time blood perfusion data, images, and video. Noninvasive and contact-free, it delivers perfusion insights before, during, and after surgery — without the need for contrast agents.

AI-generated background; product and clinical use unchanged.

References

1. Creager, M. A., Matsushita, K., Arya, S., Beckman, J. A., Duval, S., Goodney, P. P., Gutierrez, J. A. T., Kaufman, J. A., Joynt Maddox, K. E., Pollak, A. W., Pradhan, A. D., & Whitsel, L. P. (2021). Reducing Nontraumatic Lower-Extrem/ity Amputations by 20% by 2030: https://pubmed.ncbi.nlm.nih.gov/33761757